Explore our in-depth investment analysis of Tactile Systems Technology (TCMD), highlighting how its robust patent portfolio positions the company for outsized growth in the $1.46B lymphedema market by 2030. Forward-looking thesis, risks, and valuation insights for savvy investors.

Listen up, folks—markets don’t get much hotter than this right now. As...

Listen up, folks—it’s early doors on this crisp November morning...